<DOC>
	<DOCNO>NCT02556996</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled clinical trial perform Egyptian child 6-18 month age . The primary aim study determine protective efficacy oral , inactivated whole-cell enterotoxigenic Escherichia coli ( ETEC ) vaccine diarrhea associate excretion ETEC express vaccine-shared antigen one year period follow-up active surveillance . The vaccine consist mixture five formalin-killed ETEC bacteria express prevalent ETEC colonization factor recombinant cholera toxin B-subunit ( kill ETEC/rCTB vaccine ) . The placebo preparation heat-killed Escherichia coli K-12 bacteria .</brief_summary>
	<brief_title>Efficacy Oral , Killed Enterotoxigenic Escherichia Coli Vaccine Prevention Diarrhea Egyptian Infants Young Children</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Willingness parent child participate ; 2 . Plans reside catchment area continuously least one year 1 . Global developmental delay 2 . Severe malnutrition 3 . Chronic bedridden status 4 . Serious chronic disorder require chronic medication</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>